BioMaxima S.A. (WSE:BMX)
13.05
+0.10 (0.77%)
Nov 3, 2025, 2:39 PM CET
BioMaxima Revenue
BioMaxima had revenue of 12.91M PLN in the quarter ending June 30, 2025, with 3.58% growth. This brings the company's revenue in the last twelve months to 57.05M, up 16.48% year-over-year. In the year 2024, BioMaxima had annual revenue of 52.85M with 12.96% growth.
Revenue (ttm)
57.05M
Revenue Growth
+16.48%
P/S Ratio
0.97
Revenue / Employee
452.75K
Employees
126
Market Cap
55.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 52.85M | 6.07M | 12.96% |
| Dec 31, 2023 | 46.79M | -97.08M | -67.48% |
| Dec 31, 2022 | 143.87M | 64.78M | 81.91% |
| Dec 31, 2021 | 79.09M | 17.81M | 29.06% |
| Dec 31, 2020 | 61.28M | 30.67M | 100.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.04B |
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| Selvita | 373.90M |
| Celon Pharma | 206.22M |